Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 |
| Revenue growth | | | | | -100.0% | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | | | 0.0% | | |
| Research and development | | | | | | | | |
| General and administrative | 0.9 | 1.1 | 1.2 | 1.6 | 2.2 | 2.2 | 3.3 | 3.8 |
| EBIT | -1.5 | -2.4 | -2.3 | -2.8 | -3.0 | -4.7 | -4.3 | -5.5 |
| EBIT margin | | | | | | -1800.9% | | |
| Pre-tax income | -6.1 | -3.6 | -2.9 | -5.2 | -4.0 | -4.3 | -4.9 | -4.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -6.1 | -3.6 | -2.9 | -5.2 | -4.0 | -4.3 | -4.9 | 0.0 |
| Net margin | | | | | | -1654.5% | | |
| |
| Diluted EPS | ($0.02) | ($0.01) | ($0.01) | ($0.02) | ($0.04) | ($0.05) | ($0.06) | |
| Shares outstanding (diluted) | 292.8 | 272.4 | 268.0 | 215.6 | 114.0 | 95.2 | 87.0 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|